UA88879C2 - Fsh glycosylation mutant - Google Patents

Fsh glycosylation mutant

Info

Publication number
UA88879C2
UA88879C2 UAA200603350A UAA200603350A UA88879C2 UA 88879 C2 UA88879 C2 UA 88879C2 UA A200603350 A UAA200603350 A UA A200603350A UA A200603350 A UAA200603350 A UA A200603350A UA 88879 C2 UA88879 C2 UA 88879C2
Authority
UA
Ukraine
Prior art keywords
fsh
mutant
glycosylation mutant
mammal
fsh glycosylation
Prior art date
Application number
UAA200603350A
Other languages
English (en)
Ukrainian (uk)
Inventor
Луиз М. Герон
Стефен Дж. Аркинстелл
Уильям Х. Брондик
Роберт К. Кампбелл
Сюлянь Дзянь
Шон Д. Маккена
Марк Теппер
Original Assignee
Эплайд Рисерч Системз Эрс Холдинг Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эплайд Рисерч Системз Эрс Холдинг Н.В. filed Critical Эплайд Рисерч Системз Эрс Холдинг Н.В.
Publication of UA88879C2 publication Critical patent/UA88879C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Изобретение относится к новому FSH-мутанту с повышенным уровнем гликозилирования и длинным периодом полувыведения для использования при лечении бесплодного животного, индуцирование фолликулогенеза или индуцирование гиперстимуляции яичника у млекопитающего. FSH-мутант позволяет применять меньшие суммарные дозы FSH для достижения сходного или лучшего клинического результата.
UAA200603350A 2003-09-02 2004-02-09 Fsh glycosylation mutant UA88879C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49980203P 2003-09-02 2003-09-02

Publications (1)

Publication Number Publication Date
UA88879C2 true UA88879C2 (en) 2009-12-10

Family

ID=34272871

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200603350A UA88879C2 (en) 2003-09-02 2004-02-09 Fsh glycosylation mutant

Country Status (24)

Country Link
US (1) US7700112B2 (ru)
EP (1) EP1694271B1 (ru)
JP (1) JP4653090B2 (ru)
KR (1) KR101099809B1 (ru)
CN (1) CN1984926B (ru)
AT (1) ATE511829T1 (ru)
AU (1) AU2004268683B2 (ru)
BR (1) BRPI0413206A (ru)
CA (1) CA2535522A1 (ru)
CY (1) CY1112439T1 (ru)
DK (1) DK1694271T3 (ru)
EA (1) EA012175B1 (ru)
ES (1) ES2367784T3 (ru)
HK (1) HK1101315A1 (ru)
HR (1) HRP20110430T1 (ru)
IL (1) IL174037A0 (ru)
MX (1) MXPA06002119A (ru)
NO (1) NO20061446L (ru)
PL (1) PL1694271T3 (ru)
PT (1) PT1694271E (ru)
SI (1) SI1694271T1 (ru)
UA (1) UA88879C2 (ru)
WO (1) WO2005020934A2 (ru)
ZA (1) ZA200601803B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101282990B (zh) 2005-08-26 2013-04-03 阿雷斯贸易股份有限公司 糖基化干扰素-β的制备方法
JP5199112B2 (ja) * 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Ｆｓｈ又はｆｓｈ変異体を精製するための方法
KR20080087854A (ko) * 2005-12-22 2008-10-01 라보라토리스 세로노 에스.에이. Ｆｓｈ 변종
EP1981908B1 (en) * 2006-01-17 2010-11-10 Merck Serono SA Novel fsh glycosylation variant d3n
ES2532221T3 (es) * 2007-03-26 2015-03-25 Novartis Ag Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CN108676096B (zh) * 2018-05-22 2022-03-29 北京伟杰信生物科技有限公司 重组猪fsh-ctp融合蛋白及其制备方法与应用
WO2021092358A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same
CN114213523A (zh) * 2021-11-15 2022-03-22 广州源博医药科技有限公司 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US5639639A (en) 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5156957A (en) 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
US4845077A (en) 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5338835A (en) 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
CA2053864C (en) 1989-02-21 2001-11-20 Irving Boime Modified forms of reproductive hormones
US5508261A (en) 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
EP0994718B1 (en) * 1997-06-20 2005-08-17 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
IL141063A (en) * 1998-08-07 2005-06-19 Applied Research Systems Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility
CA2397680A1 (en) * 2000-01-27 2001-08-02 Applied Research Systems Ars Holding N.V. Use of fsh for treating infertility
US20020127652A1 (en) * 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
AU2001231531A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Follicle stimulating hormones
AU2002368265B2 (en) 2001-10-22 2007-06-07 Merck Serono Sa Mutant glycoproteins

Also Published As

Publication number Publication date
US20050100989A1 (en) 2005-05-12
MXPA06002119A (es) 2006-05-31
PT1694271E (pt) 2011-07-07
EP1694271A2 (en) 2006-08-30
CA2535522A1 (en) 2005-03-10
AU2004268683A2 (en) 2005-03-10
WO2005020934A3 (en) 2007-02-15
US7700112B2 (en) 2010-04-20
AU2004268683A1 (en) 2005-03-10
JP2007508245A (ja) 2007-04-05
PL1694271T3 (pl) 2011-11-30
AU2004268683B2 (en) 2010-06-24
WO2005020934A2 (en) 2005-03-10
ATE511829T1 (de) 2011-06-15
CY1112439T1 (el) 2015-12-09
IL174037A0 (en) 2006-08-01
HRP20110430T1 (hr) 2011-07-31
CN1984926B (zh) 2012-04-11
SI1694271T1 (sl) 2011-08-31
BRPI0413206A (pt) 2006-10-03
JP4653090B2 (ja) 2011-03-16
KR101099809B1 (ko) 2011-12-27
NO20061446L (no) 2006-03-30
CN1984926A (zh) 2007-06-20
HK1101315A1 (en) 2007-10-12
ZA200601803B (en) 2007-05-30
DK1694271T3 (da) 2011-09-12
ES2367784T3 (es) 2011-11-08
EA012175B1 (ru) 2009-08-28
EP1694271B1 (en) 2011-06-08
EA200600526A1 (ru) 2007-04-27
KR20070029620A (ko) 2007-03-14

Similar Documents

Publication Publication Date Title
MXPA05011925A (es) Rociador, accionador de rociador y metodo para fabricarlos.
EP1463531A4 (en) PROCESS FOR INHIBITING OKULAR PROCESSES
TNSN06022A1 (en) Use of calcitonin in osteoarthritis
DE60124710D1 (de) Analoge des glucagon ähnlichen peptid-1
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
SI1718677T1 (sl) Monovalentni protitelesni fragmenti, uporabni kot zdravila
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
EP1543034A4 (en) TREATMENT AND PROPHYLAXIS WITH 4-1BB BINDING AGENTS
CY1112439T1 (el) Μεταλλαγμα fsh-γλυκοζυλιωσης
PL367065A1 (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
AU2003223934A8 (en) Recombinant bet. v. 1. allergen mutants, methods and process thereof
WO2002073196A3 (en) Individualization of therapy with antipsychotics
AU2003240416A1 (en) Elastic exercise apparatus
MY122838A (en) Treating allergic and inflammatory conditions
WO2007084441A3 (en) Novel fsh glycosylation variant d3n
MX2008008322A (es) Mutantes de fsh.
EP1808179A3 (en) Use of HSP20 for promoting wound healing and/or reducing scar formation
AU2002326285A1 (en) Method for treating psoriasis by using an il-17d antagonist
DE50202331D1 (de) Verwendung eines phosphatadsorbers gegen gefässerkrankungen
GB0422989D0 (en) Methods and agents for the treatment of cancer
AP2000001945A0 (en) Leishmania cysteine proteinases.
IL164200A0 (en) A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose